Genetic and pharmacological proof-of-concept studies imply profilin-1 as a potential target for blocking metastatic colonization of breast cancer cells

被引：0
|
作者：
Ding, Zhijie [1 ]
Joy, Marion [1 ]
Vollmer, Laura [1 ]
Stern, Andrew [1 ]
Vogt, Andreas [1 ]
Roy, Partha [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Profilin-1 is a key determinant for tumorigenic potential of breast cancer cells
    Jiang, Chang
    Ding, Zhijie
    Joy, Marion
    Vollmer, Laura
    Gau, Dave
    Kim, Su Hyeong
    Singh, Shivendra
    Vogt, Andreas
    Roy, Partha
    [J]. CANCER RESEARCH, 2015, 75
  • [2] A balanced Profilin-1 expression promotes stemness, outgrowth and tumorigenic potential of breast cancer cells
    Jiang, C.
    Ding, Z.
    Vollmer, L.
    Joy, M. E.
    Kim, S.
    Boettcher, R. T.
    Condeelis, J. S.
    Singh, S.
    Vogt, A.
    Roy, P.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [3] A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells
    Jiang, Chang
    Ding, Zhijie
    Joy, Marion
    Chakraborty, Souvik
    Kim, Su Hyeong
    Bottcher, Ralph
    Condeelis, John
    Singh, Shivendra
    Roy, Partha
    [J]. CELL CYCLE, 2017, 16 (24) : 2366 - 2373
  • [4] First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study
    Bardol, Thomas
    Eslami-S, Zahra
    Masmoudi, Doryan
    Alexandre, Marie
    de Labarre, Marie Duboys
    Bobrie, Angelique
    D'Hondt, Veronique
    Guiu, Severine
    Kurma, Keerthi
    Cayrefourcq, Laure
    Jacot, William
    Alix-Panabieres, Catherine
    [J]. CANCER MEDICINE, 2024, 13 (01):
  • [5] The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
    Stebbing, Justin
    Payne, Rachel
    Reise, Justine
    Frampton, Adam E.
    Avery, Miranda
    Woodley, Laura
    Di Leo, Angelo
    Pestrin, Marta
    Krell, Jonathan
    Coombes, R. Charles
    [J]. PLOS ONE, 2013, 8 (05):
  • [6] TRA-1-60-positive/CD45low cells found in the peripheral blood of prostate cancer patients with metastatic disease - A proof-of-concept study
    Schafer, Claudia
    Ju, Yawen
    Tak, Youngbin
    Vazquez, Cesar
    Han, Sangyoon J.
    Tan, Edwin
    Shay, Jerry W.
    Holmqvist, Mats
    Danuser, Gaudenz
    Schopperle, William M.
    Bubley, Glenn
    [J]. HELIYON, 2020, 6 (01)
  • [7] Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target
    Sarkar, Ruma
    Mukherjee, Sutapa
    Biswas, Jaydip
    Roy, Madhumita
    [J]. FREE RADICAL RESEARCH, 2016, 50 (01) : 84 - 100
  • [8] TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
    Cordani, Nicoletta
    Mologni, Luca
    Piazza, Rocco
    Tettamanti, Pietro
    Cogliati, Viola
    Mauri, Mario
    Villa, Matteo
    Malighetti, Federica
    Di Bella, Camillo
    Jaconi, Marta
    Cerrito, Maria Grazia
    Cavaletti, Guido
    Lavitrano, Marialuisa
    Cazzaniga, Marina Elena
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [9] Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
    Marta Pestrin
    Silvia Bessi
    Fabio Puglisi
    Alessandro M. Minisini
    Giovanna Masci
    Nicola Battelli
    Alberto Ravaioli
    Lorenzo Gianni
    Roberta Di Marsico
    Carlo Tondini
    Stefania Gori
    Charles R. Coombes
    Justin Stebbing
    Laura Biganzoli
    Marc Buyse
    Angelo Di Leo
    [J]. Breast Cancer Research and Treatment, 2012, 134 : 283 - 289
  • [10] Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
    Pestrin, Marta
    Bessi, Silvia
    Puglisi, Fabio
    Minisini, Alessandro M.
    Masci, Giovanna
    Battelli, Nicola
    Ravaioli, Alberto
    Gianni, Lorenzo
    Di Marsico, Roberta
    Tondini, Carlo
    Gori, Stefania
    Coombes, Charles R.
    Stebbing, Justin
    Biganzoli, Laura
    Buyse, Marc
    Di Leo, Angelo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 283 - 289
1